Literature DB >> 25674515

Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review.

Rushna Firdaus1, Kallol Saha1, Aritra Biswas1, Provash Chandra Sadhukhan1.   

Abstract

Hepatitis C virus (HCV) is an emerging infection worldwide and the numbers of persons infected are increasing every year. Poor blood transfusion methods along with unsafe injection practices are potential sources for the rapid spread of infection. Early detection of HCV is the need of the hour especially in high risk group population as these individuals are severely immunocompromised. Enzyme Immunoassays are the most common detection techniques but they provide no evidence of active viremia or identification of infected individuals in the antibody-negative phase and their efficacy is limited in individuals within high risk group population. Molecular virological techniques have an important role in detecting active infection with utmost specificity and sensitivity. Technologies for assessment of HCV antibody and RNA levels have improved remarkably, as well as our understanding of how to best use these tests in patient management. This review aims to give an overview of the different serological and molecular methods employed in detecting HCV infection used nowadays. Additionally, the review gives an insight in the new molecular techniques that are being developed to improve the detection techniques particularly in High Risk Group population who are severely immunocompromised.

Entities:  

Keywords:  Enzyme immunoassay; High risk group population; Molecular detection; Nucleic acid amplification assays; Polymerase chain reaction

Year:  2015        PMID: 25674515      PMCID: PMC4308525          DOI: 10.5501/wjv.v4.i1.25

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  71 in total

1.  HCV genotyping by three methods: analysis of discordant results based on sequencing.

Authors:  M Furione; L Simoncini; M Gatti; F Baldanti; M Grazia Revello; G Gerna
Journal:  J Clin Virol       Date:  1999-08       Impact factor: 3.168

Review 2.  Clinical use of hepatitis C virus tests for diagnosis and monitoring during therapy.

Authors:  C Morishima; D R Gretch
Journal:  Clin Liver Dis       Date:  1999-11       Impact factor: 6.126

3.  Misclassification of HCV-viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase reactivity.

Authors:  L H Tobler; S L Stramer; S H Kleinman; J P Brodsky; D S Todd; M P Busch
Journal:  Transfusion       Date:  2001-12       Impact factor: 3.157

4.  Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.

Authors:  Marcel Beld; Roel Sentjens; Sjoerd Rebers; Christine Weegink; Jan Weel; Cees Sol; René Boom
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Conformational changes accompanying self-assembly of the hepatitis C virus core protein.

Authors:  Meghan Kunkel; Stanley J Watowich
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

Review 6.  Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.

Authors:  N Kato
Journal:  Microb Comp Genomics       Date:  2000

7.  In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.

Authors:  M Yanagi; M St Claire; S U Emerson; R H Purcell; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 8.  Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes.

Authors:  J McLauchlan
Journal:  J Viral Hepat       Date:  2000-01       Impact factor: 3.728

9.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

10.  Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.

Authors:  S C Lee; A Antony; N Lee; J Leibow; J Q Yang; S Soviero; K Gutekunst; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

View more
  12 in total

1.  Synthesis of comb-shaped DNA using a non-nucleosidic branching phosphoramidite.

Authors:  Satheesh Ellipilli; John D Phillips; Jennifer M Heemstra
Journal:  Org Biomol Chem       Date:  2018-06-08       Impact factor: 3.876

2.  Frequency of nucleotide sequence variations in the internal ribosome entry site region of hepatitis C virus RNA isolated from responding and non-responding patients with hepatitis C virus genotype 3 infection.

Authors:  Anzar Ashraf; Anita Chakravarti; Priyamvada Roy; Premashish Kar; Oves Siddiqui
Journal:  Virusdisease       Date:  2016-08-06

3.  Analysis of hepatitis C infection using Raman spectroscopy and proximity based classification in the transformed domain.

Authors:  Anabia Sohail; Saranjam Khan; Rahat Ullah; Shahzad Ahmad Qureshi; Muhammad Bilal; Asifullah Khan
Journal:  Biomed Opt Express       Date:  2018-04-03       Impact factor: 3.732

Review 4.  Update on hepatitis B and C virus diagnosis.

Authors:  Livia Melo Villar; Helena Medina Cruz; Jakeline Ribeiro Barbosa; Cristianne Sousa Bezerra; Moyra Machado Portilho; Letícia de Paula Scalioni
Journal:  World J Virol       Date:  2015-11-12

5.  Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.

Authors:  Mário F Neto; Matthew A Butzler; Jennifer L Reed; Xiang Rui; Mark J Fisher; David M Kelso; Sally M McFall
Journal:  J Virol Methods       Date:  2017-06-30       Impact factor: 2.014

6.  Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil.

Authors:  Cintia Costi; Tarciana Grandi; Maria Laura Halon; Márcia Susana Nunes Silva; Cláudia Maria Dornelles da Silva; Tatiana Schäffer Gregianini; Lia Gonçalves Possuelo; Carla Adriane Jarczewski; Christian Niel; Maria Lucia Rosa Rossetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-04       Impact factor: 2.743

7.  Development of a Method for Screening and Genotyping of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes.

Authors:  Shrikant Dashrath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Taisun Kim
Journal:  ACS Omega       Date:  2020-05-08

Review 8.  HCV Detection, Discrimination, and Genotyping Technologies.

Authors:  Shrikant Dashrath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Taisun Kim
Journal:  Sensors (Basel)       Date:  2018-10-12       Impact factor: 3.576

9.  A Prospective Hospital Study to Evaluate the Diagnostic Accuracy of Rapid Diagnostic Tests for the Early Detection of Leptospirosis in Laos.

Authors:  Sabine Dittrich; Latsaniphone Boutthasavong; Dala Keokhamhoung; Weerawat Phuklia; Scott B Craig; Suhella M Tulsiani; Mary-Anne Burns; Steven L Weier; David A B Dance; Viengmon Davong; Manivanh Vongsouvath; Mayfong Mayxay; Rattanaphone Phetsouvanh; Paul N Newton; Kate Woods
Journal:  Am J Trop Med Hyg       Date:  2018-02-22       Impact factor: 2.345

10.  Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples.

Authors:  Shrikant Dasharath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Wasun Chantratita; Viroj Pongthanapisith; Laxman Uddhav Nawale; Taisun Kim
Journal:  Virol J       Date:  2018-07-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.